Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.
about
The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancerIntestinal microbiota transplant - current state of knowledgeRegulation of immune cell function by short-chain fatty acidsDevelopment and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signalsChemically defined diet alters the protective properties of fructo-oligosaccharides and isomalto-oligosaccharides in HLA-B27 transgenic ratsAntimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosisRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43Human gut microbiota and healthy aging: Recent developments and future prospectiveDysfunction of the intestinal microbiome in inflammatory bowel disease and treatmentThe Microbiota, Immunoregulation, and Mental Health: Implications for Public Health.Dietary intake of soluble fiber and risk of islet autoimmunity by 5 y of age: results from the TEDDY study.Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity.Caecal pH is a biomarker of excessive colonic fermentation.No association of dietary fiber intake with inflammation or arterial stiffness in youth with type 1 diabetes.pH-Mediated Microbial and Metabolic Interactions in Fecal Enrichment Cultures.Epithelial cell-specific MyD88 signaling mediates ischemia/reperfusion-induced intestinal injury independent of microbial status.Diet Hypotheses in Light of the Microbiota Revolution: New Perspectives.16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects.Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.The function of our microbiota: who is out there and what do they do?The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon.Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.Alteration of intestinal microbiota in mice orally administered with salmon cartilage proteoglycan, a prophylactic agent.High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects.Modulation of immune homeostasis by commensal bacteria.Colorectal Oncogenesis and Inflammation in a Rat Model Based on Chronic Inflammation due to Cycling DSS Treatments.Mucosal Immune Development in Early Life: Setting the Stage.The Differential Proteome of the Probiotic Lactobacillus acidophilus NCFM Grown on the Potential Prebiotic Cellobiose Shows Upregulation of Two β -Glycoside HydrolasesShort-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligandsPrebiotics, Fermentable Dietary Fiber, and Health Claims.The gut microbiome of healthy Japanese and its microbial and functional uniqueness.Effects of Early Intervention with Sodium Butyrate on Gut Microbiota and the Expression of Inflammatory Cytokines in Neonatal Piglets.Effects of Liver Resection on Hepatic Short-Chain Fatty Acid Metabolism in HumansFecal microbial transplant for the treatment of pediatric inflammatory bowel disease.Probiotic therapy as a novel approach for allergic disease.Quantification of in Vivo Colonic Short Chain Fatty Acid Production from Inulin.Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.The effects of commensal bacteria on innate immune responses in the female genital tract.
P2860
Q24306831-23064C62-3F8D-4FC8-ADFD-5178B980C16DQ26741017-80FBD336-EABA-4568-801A-C75C29FE0C80Q26748416-FB79F54C-9661-414F-B967-3779FBA25B92Q26829933-6FB465D4-4255-444C-8140-BE9A43EE05BEQ27332418-48B6C223-51F7-4EF0-A57C-DAA7AE6F33FEQ28081831-AB027100-181E-45D6-8882-94049D9399F5Q28509150-FEDCE9B8-CD21-4C17-8D08-2DC1D3CBCE97Q28586306-ADBF5FC4-FEB7-401D-9B4A-13AEB8114784Q28710518-5D614335-9B5B-4A06-8EC6-7C9EBEFE547AQ30248903-980FBD74-CD51-4192-938B-5C0679EE53D9Q30357281-D1890896-C0E1-4124-A221-DFC21EF89283Q31123584-D7CA009F-F970-44C9-A0F3-5272BFB5D120Q33346196-49EB6F17-7A1A-441C-9E2D-C46BDF744995Q33564151-4E4D0064-9E40-4959-A457-B13E72441BBCQ33570748-D23F6419-29FD-463E-8105-0FE3C5C1DA01Q33634286-2B4E2AF4-54D9-4200-A96E-D59F52A5730AQ33689251-07F4F3AA-3E9C-4425-A96F-D7A6460858A4Q33851769-948E5A5C-FE38-4B0D-A276-010FAE80A8A2Q33879834-EB8D81F1-D78B-4576-8493-0302302EE300Q33920905-B82F1A3F-29E1-40C2-A421-50B672AA1518Q34120699-E754358C-0288-4BAC-802F-1954980007E2Q34392557-60F9E70B-DA94-459A-9EF6-7161D0FDABC7Q34452017-6F7BCD57-3C7D-417C-A94C-46884132BC0EQ34900690-661EB5D4-4F24-4C56-B9AB-8950140DD703Q34990474-19583C23-7DEF-44C2-B1EB-1A1F29AA18E7Q35043961-B13A4A72-1040-43C8-BC04-8D95CA1D006FQ35069784-1EF20EBD-B978-45A0-A551-B23842916EF8Q35295244-876F0E31-879E-4820-A1A9-692D4550124EQ35558518-258417A4-F469-4C63-8CF4-E4654329E5FFQ35563433-0C52BC6D-AD3D-4260-91F8-B6BE75168CA9Q35784465-65400633-37EF-462D-B1F1-736C13AA9534Q35895688-04501FCE-0B0F-40CE-8800-50FEFE74495DQ35948206-9BA66CC1-94E0-42D4-9A9F-0A9360A044B6Q36128519-18CF750E-A50D-4679-A59E-694FB33D0E0EQ36189874-9D186E23-FE07-4B9E-AA7B-39467D5055B2Q36241633-3A50ABEE-F9E3-415D-B8C6-F018F4EF08F8Q36250265-0F92F01E-519A-449D-A481-D7649D378B4AQ36329760-0F96F64D-4551-4495-835C-778D3793A452Q36453623-8461029D-1958-482B-90FD-421A5915C649Q36634992-EF7DC57A-4879-46B7-ACE4-37C3FC096FEB
P2860
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Anti-inflammatory properties o ...... to inflammatory bowel disease.
@ast
Anti-inflammatory properties o ...... to inflammatory bowel disease.
@en
type
label
Anti-inflammatory properties o ...... to inflammatory bowel disease.
@ast
Anti-inflammatory properties o ...... to inflammatory bowel disease.
@en
prefLabel
Anti-inflammatory properties o ...... to inflammatory bowel disease.
@ast
Anti-inflammatory properties o ...... to inflammatory bowel disease.
@en
P2093
P2860
P356
P1476
Anti-inflammatory properties o ...... to inflammatory bowel disease
@en
P2093
Alexander Vidal
Fredrik Westberg
Martin Kjerrulf
Sofia Tedelind
P2860
P304
P356
10.3748/WJG.V13.I20.2826
P407
P577
2007-05-01T00:00:00Z